PUBLISHER: Grand View Research | PRODUCT CODE: 1571776
PUBLISHER: Grand View Research | PRODUCT CODE: 1571776
The global protein detection and quantification market size is expected to reach USD 4.83 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.0% from 2024 to 2030. The introduction of assay methods that enable protein estimation at lower limits of concentration in order to monitor the changes is expected to drive growth in the coming years.
Governments are encouraging the research activities by raising funds in the field of proteomics industry and thus the protein detection and quantification market is anticipated to grow at a significant pace in the coming years. The presence of organizations such as the Human Proteome Organization, National Cancer Institute (NCI), and Genomic Health Inc. promotes funding to support R&D and product development exercises pertaining to the field of proteomics.
Growing need to understand chronic diseases at a molecular level and develop therapeutic solutions is expected to encourage these organizations to fund research and development programs. In addition, Public Health Genomics at the National Cancer Institute (NCI) promotes the integration of personalized medicine and genomics into public health cancer research in an attempt to reduce the burden of cancer across the globe
Although technological advancements continue to take place for simplification protein estimation, high cost of technology and assays are anticipated to restrict the usage of these assays and technologies under certain circumstances. For instance, Mass Spectroscopy (MS) which is often used for functional proteomics is considered expensive and slow by researchers. In targeted MS, custom antibodies are required for each target to perform immunoaffinity enrichment of peptides. This process is observed to be expensive as well as lengthy.